- TNFA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-K/A Filing
TNF Pharmaceuticals (TNFA) 10-K/A2016 FY Annual report (amended)
Filed: 18 Apr 17, 12:00am
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Amendment to No. 1 to Form S-3 dated November 15, 2016 of Akers Biosciences, Inc. and the related Prospectus included therein, of our report dated April 11, 2017, relating to our audit of the consolidated financial statements of Akers Biosciences, Inc. appearing in the Company’s Annual Report on Form 10-K of Akers Biosciences, Inc. for the year ended December 31, 2016.
/s/ Morison Cogen LLP | |
Blue Bell, Pennsylvania | |
April 18, 2017 |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.